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Amyloid-b (Ab) induces neuronal loss and cognitive defi-
cits and is believed to be a prominent cause of Alzheimer’s
disease (AD). However, the cellular mechanism of the
pathogenesis is not fully understood. Here we report that
Fcg-receptor IIb (FcgRIIb) mediates Ab neurotoxicity and
neurodegeneration. We found that FcgRIIb is significantly
up-regulated in the hippocampus of AD brains and neu-
ronal cells exposed to Ab1-42. Neuronal FcgRIIb activates
ER stress and caspase-12, and FcgRIIb knockout primary
neurons are resistant to Ab1-42-induced cell death in vitro.
FcgRIIb deficiency ameliorates Ab1-42-induced inhibition
of long-term potentiation and inhibits the reduction of
synaptic density by naturally secreted Ab. Moreover,
genetic depletion of FcgRIIb rescues the memory impair-
ments in AD model mice. In an action mode of FcgRIIb in
Ab neurotoxicity, we found that soluble Ab1-42 oligomers
interact with FcgRIIb in vitro and in AD brains, and inhi-
bition of their interaction blocks Ab1-42 neurotoxicity.
Thus, we conclude that FcgRIIb has an aberrant but essen-
tial role in Ab1-42-mediated neuronal dysfunction, pro-
viding insight into Ab neuropathology.
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